Capricor Therapeutics, Inc. (CAPR): A Bull Case Theory

We came across a bullish thesis on Capricor Therapeutics, Inc. (CAPR) on wallstreetbets Subreddit Page by androidmj. In this article, we will summarize the bulls’ thesis on CAPR. Capricor Therapeutics, Inc. (CAPR)’s share was trading at $12.65 as of March 5th.

A laboratory filled with modern equipment, scientists examining the latest biotechnology breakthroughs.

Capricor Therapeutics (CAPR) is set for a high-stakes FDA decision on its Duchenne muscular dystrophy (DMD) therapy, Deramiocel...